3,4-Methylenedioxymethamphetamine (Ecstasy) Inhibits Dyskinesia Expression and Normalizes Motor Activity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Primates

Ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] was shown to prolong the action of l-3,4-dihydroxyphenylalanine (l-DOPA) while suppressing dyskinesia in a single patient with Parkinson's disease (PD). The clinical basis of this effect of MDMA is unknown but may relate to its actions on eithe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurosci
Main Authors: Iravani, Mahmoud M., Jackson, Michael J., Kuoppamäki, Mikko, Smith, Lance A., Jenner, Peter
Formato: Artigo
Idioma:Inglês
Publicado em: Society for Neuroscience 2003
Assuntos:
Behavioral/Systems/Cognitive
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6740822/
https://ncbi.nlm.nih.gov/pubmed/14534244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.23-27-09107.2003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados